Nextremity Solutions LLC announced it has obtained ISO 13485 Certification of its Quality Management System and CE Mark Certification of the NEXTRA Hammertoe Correction System. The NEXTRA System is a key component to the company's forefoot reconstruction portfolio and was introduced for limited release at the American Orthopaedic Foot & Ankle Society Congress, July 13-15 in Keystone, Colorado. The global launch of the product will commence in early 2012.
Arthur Alfaro, President & CEO, comments that, "We are very proud to have achieved ISO certification at such an early stage in the company's development and conform to a global quality standard for medical devices. The additional CE Mark Certification of the NEXTRA Hammertoe System allows us to now initiate the global commercial release of our First-in-Class surgical procedure kit and implant for treating a foot deformity which affects 10 to 20% of the population. The company will now mobilize its resources to train orthopaedic surgeons, podiatric surgeons and trauma surgeons in what we believe will be a game changing product. NEXTRA is our first product in a series of highly differentiated surgical solutions for one of the fastest growing sectors in the medical device industry."
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement